Insulin Glargine Induced Persistent Intractable Hypoglycemia, with Variable Presentations in Older Diabetic Patients: An Experience of 4 Cases

Journal of the American Medical Directors Association

Volumn 10, Issue 9, 2009, Pages 672-673

  Kumari, Jaishree ^a   Dharmarajan, T S ^a,b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE;

ADULT; AGED; CASE REPORT; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTINUOUS INFUSION; CORONARY ARTERY DISEASE; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DIET; DISEASE DURATION; DRUG DOSE REDUCTION; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOGLYCEMIA; LETHARGY; LETTER; MALE; PERIPHERAL VASCULAR DISEASE; SEIZURE; ULCER; WEAKNESS;

EID: 70350352769     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2009.08.005     Document Type: Letter

References (6)

1. Goykhman S., Drincic A., Desmangles J.C., and Rendell M. Insulin glargine: A review 8 years after its introduction. Expert Opin Pharmacother 10 (2009) 705-718
2. Bazzano L.A., Lee L.J., Shi L., et al. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: A meta-analysis of randomized controlled trials. Diabet Med 25 (2008) 924-932
3. Dailey G., and Strange P. Lower severe hypoglycemia risk: Insulin glargine versus NPH insulin in type 2 diabetes. Am J Manag Care 14 (2008) 25-30
4. Singh S.R., Ahmad F., Lal A., et al. Efficacy and safety of insulin analogues for the management of diabetes mellitus: A meta-analysis. CMAJ 180 (2009) 385-397
5. Mathieu C., and Robbrecht S. Reaching glycaemic targets while minimizing hypoglycemia in insulin-treated type 2 diabetes patients. Diabetes Obes Metab 10 (2008) 14-23
6. Dharmarajan T.S., Russell R.O., and Dabhi K. Recurrent, refractory hypoglycemia presenting as a behavioral disorder in an older woman. J Am Geriatr Soc 47 (1999) 380-381